Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication201220132014201520162017201820192020202120222023202420252026 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyProduct Development Unit Dec 2021 Nature Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta Autoren Ulrich L et al. Dec 2021 Pathogens Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General Autoren Pischke S et al. Dec 2021 Viruses αVβ3 Integrin Expression Is Essential for Replication of Mosquito and Tick-Borne Flaviviruses in Murine Fibroblast Cells Autoren Reis VPD et al. Dec 2021 Antimicrob Agents Chemother Bloodstream infections caused by Magnusiomyces capitatus and Magnusiomyces clavatus: epidemiological, clinical and microbiological features of two emerging yeast species Autoren Noster J et al. Dec 2021 Cell Rep Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses Autoren Wratil PR et al. Dec 2021 medRxiv mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant Autoren Garcia-Beltran WF et al. Dec 2021 Trop Med Infect Dis Pilot Malacology Surveys for the Intermediate Hosts of Schistosomiasis in Rural and Semi-Urban Areas of the Moyen-Ogooué Province, Gabon Autoren Agobé JCD et al. Dec 2021 PLoS Negl Trop Dis TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature Autoren Nordmann T et al. Dec 2021 PLoS One Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors Autoren Hamann MV et al. Dec 2021 Front Cell Infect Microbiol Short-Chain Fatty Acid and FFAR2 Activation - A New Option for Treating Infections? Autoren Schlatterer K Peschel A Kretschmer D Dec 2021 Nucleic Acids Res Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread Autoren Ambike S et al. Dec 2021 Front Immunol Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19 Autoren Mellinghoff SC et al. Dec 2021 Clin Microbiol Infect European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM -European Society of intensive care Medicine) Autoren Paul M et al. Dec 2021 Cell The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic Autoren Hoffmann M et al. Dec 2021 Ann Clin Microb Antimicrob Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients Autoren Elion Assiana DO et al. Dec 2021 Clin Immunol Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants Autoren Hargreaves CE et al. Dec 2021 BMJ Open Seroprevalence of SARS-CoV-2 in urban settings in three sub-Saharan African countries (SeroCoV): a study protocol for a household-based cross-sectional prevalence study using two-stage cluster sampling Autoren Lorenz E et al. Dec 2021 J Infect T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option Autoren Mellinghoff SC et al. Dec 2021 Cell Host Microbe Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers Autoren Vanshylla K et al. Dec 2021 JHEP Rep Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality Autoren Reißing J et al. Dec 2021 J Allergy Clin Immunol Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency Autoren Yang L et al. Dec 2021 J Intern Med Liver damage promotes pro-inflammatory T-cell responses against apolipoprotein B-100 Autoren Plochg BFJ et al. Dec 2021 Cell SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis Autoren Wendisch D et al. Dec 2021 PLoS Biol Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus Autoren Amanat F et al. Dec 2021 Nat Commun Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation Autoren Tabata K et al. Pagination Previous page ‹‹ Seite 128 Seite 129 Seite 130 Seite 131 Current page 132 Seite 133 Seite 134 Seite 135 Seite 136 Seite 128 Seite 129 Seite 130 Seite 131 Seite 132 Seite 133 Seite 134 Seite 135 Seite 136 Next page ››
Dec 2021 Nature Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta Autoren Ulrich L et al.
Dec 2021 Pathogens Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General Autoren Pischke S et al.
Dec 2021 Viruses αVβ3 Integrin Expression Is Essential for Replication of Mosquito and Tick-Borne Flaviviruses in Murine Fibroblast Cells Autoren Reis VPD et al.
Dec 2021 Antimicrob Agents Chemother Bloodstream infections caused by Magnusiomyces capitatus and Magnusiomyces clavatus: epidemiological, clinical and microbiological features of two emerging yeast species Autoren Noster J et al.
Dec 2021 Cell Rep Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses Autoren Wratil PR et al.
Dec 2021 medRxiv mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant Autoren Garcia-Beltran WF et al.
Dec 2021 Trop Med Infect Dis Pilot Malacology Surveys for the Intermediate Hosts of Schistosomiasis in Rural and Semi-Urban Areas of the Moyen-Ogooué Province, Gabon Autoren Agobé JCD et al.
Dec 2021 PLoS Negl Trop Dis TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature Autoren Nordmann T et al.
Dec 2021 PLoS One Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors Autoren Hamann MV et al.
Dec 2021 Front Cell Infect Microbiol Short-Chain Fatty Acid and FFAR2 Activation - A New Option for Treating Infections? Autoren Schlatterer K Peschel A Kretschmer D
Dec 2021 Nucleic Acids Res Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread Autoren Ambike S et al.
Dec 2021 Front Immunol Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19 Autoren Mellinghoff SC et al.
Dec 2021 Clin Microbiol Infect European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM -European Society of intensive care Medicine) Autoren Paul M et al.
Dec 2021 Cell The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic Autoren Hoffmann M et al.
Dec 2021 Ann Clin Microb Antimicrob Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients Autoren Elion Assiana DO et al.
Dec 2021 Clin Immunol Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants Autoren Hargreaves CE et al.
Dec 2021 BMJ Open Seroprevalence of SARS-CoV-2 in urban settings in three sub-Saharan African countries (SeroCoV): a study protocol for a household-based cross-sectional prevalence study using two-stage cluster sampling Autoren Lorenz E et al.
Dec 2021 J Infect T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option Autoren Mellinghoff SC et al.
Dec 2021 Cell Host Microbe Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers Autoren Vanshylla K et al.
Dec 2021 JHEP Rep Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality Autoren Reißing J et al.
Dec 2021 J Allergy Clin Immunol Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency Autoren Yang L et al.
Dec 2021 J Intern Med Liver damage promotes pro-inflammatory T-cell responses against apolipoprotein B-100 Autoren Plochg BFJ et al.
Dec 2021 Cell SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis Autoren Wendisch D et al.
Dec 2021 PLoS Biol Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus Autoren Amanat F et al.
Dec 2021 Nat Commun Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation Autoren Tabata K et al.
